HPV

…

Physician’s Briefing Staff FRIDAY, Aug. 5, 2022 (HealthDay News) -- Human papillomavirus (HPV) vaccination seems to reduce the risk for cervical intraepithelial neoplasia grade 2 or higher (CIN2+)…

PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by OmniPathology, please note that the second sentence in paragraph one should read "The Oral HPV Test is a lab-developed test…

PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus (HPV) that can cause cancer. The Oral…

New York, June 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Human Papillomavirus (HPV) Vaccine Market Size, Share, Growth, Revenue, Trends, Forecast to 2028 - COVID-19 Impact and Global Analysis…

Los Angeles, California, June 10, 2022 (GLOBE NEWSWIRE) -- Personal injury lawyers from the Baum Hedlund law firm have released a new Gardasil Injury Compensation Guide to help victims who allege the human papillomavirus (HPV) vaccine…

KANSAS CITY, Mo. (AP) — Geico could be required to pay a Missouri woman $5.2 million because she said she contracted a sexually transmitted disease while having sex in the car of a man who is insured by the company.A…

Alternating 2-vector therapy showed superior antigen-specific T cell responses, more robust anti-tumor activity and similar tolerability vs. single-vector therapyPhase 2 to proceed with alternating 2-vector therapy in combination with…

HPV 'herd immunity' now helping vaccinated, unvaccinated womenVaccination against the virus that causes most cervical cancers has spurred a widespread reduction of infections among young Americans — including those who are…

Rates of cancer screening recovered somewhat during 2021 but remained well below historical rates prior to COVID. (FiercePharma) Sierra Oncology…